Nanotechnology Drug Delivery Market Synopsis

Nanotechnology Drug Delivery Market Size Was Valued at USD 95.7 Billion in 2023, and is Projected to Reach USD 213.2 Billion by 2032, Growing at a CAGR of 9.3% From 2024-2032.

Nanotechnology Drug Delivery Market is the utilization of nanotechnology in drug delivery to desired tissues or cells in the body. Nanotechnology means working at nano-scale: particles, atoms and molecules; the ability to create nanoparticles that can deliver drugs to the target cells, tissues or organs with better efficiency, accuracy and results. This method maximizes the bioavailability and stability of the drugs, controls release, reduces side effects of drug and general impact on health of the patient. Use of nanotechnology in drug delivery has brought change in various areas like oncology, cardiovascular disorders and neurological disorders and have great aspect for personalized medicine and better therapeutic index.

• The Nanotechnology Drug Delivery Market has been expanding in the current years mainly attributed by growth in incidence of chronic diseases, need for precise medication delivery and growth in nanotechnology. This paper looks at the role of nanotechnology in medicine as a tool for improving drug effectiveness and minimizing harm from side effects of drugs. This applying of the technology makes it easier to avoid system exposure and enhance the efficacy of the remedy. The use of nanomaterials including liposome, polymeric nanoparticles, and solid lipid nanoparticles in drug delivery system has facilitated new approaches for managing diseases like cancer, cardiovascular diseases among others and diabetes.
• Secondly, there has been growing interest and investment by drug manufacturing companies especially in the application of nanotechnology in drug delivery systems, together with the support of government policies to encourage development in this field. Due to the push for better and better treatments of diseases which cannot be treated well with drugs, there has been a lot of investment in this sector. One of the challenges of drug delivery include solubility and bioavailability of the drug with a view of delivering the therapeutically active dose to the intended site, a factor that can be managed by nanoparticles. Other factors that are asserted to be driving the nanotechnology based products in the market in the next few years are gene therapy, immunotherapy, and innovative diagnostic tools.

Nanotechnology Drug Delivery Market Trend Analysis

Increasing Focus on Oncology Nanomedicine

• Perhaps one of the most potent trends in the Nanotechnology Drug Delivery Market is oncology nanomedicine. Tumor is among the main causes of death worldwide, and conventional treatments such as chemotherapy are known to exert severe side effects attributed to the non-specificity of the treatment. The former can be addressed by Nanotechnology – this exposes the anti-cancer drugs directly on the tumor cells and not normal cells. The last few years have witnessed progressive work to establish that nanoparticle-based drug delivery systems can address issues such as poor solubility of hydrophobic drugs, enhanced intracellular uptake and favorable drug release profiles. Nanoparticle targeting, imaging, and drug delivery in tumor treatment is widely researched and developed at present. Thus, the number of nanotechnology-based drugs approved for the treatment of cancer grows year by year and will continue to grow in the future as new therapies are developed.

Growing Demand for Personalized Medicine

• The increasing adoption of products in nanotechnology in health sector and especially in drug business constitutes a major driving force to the Nanotechnology Drug Delivery Market.. It is a medical model that focuses on the variation from individual to individual genetic variations and environment that the patient exist in and his or her lifestyle. Nanotechnology helps to create drug delivery systems that have characteristics that can be chosen depending on the patient’s needs and provide better treatment. According to enhanced pharmacokinetics and biodistribution, nanotechnology based systems can deliver targeted doses to specified area of body influencing the condition of patient’s diseases such as cancer, autoimmune diseases and cardiovascular diseases. The increased awareness of precision medicine in populations alongside the progress of genomic and biomarker identification play a critical role in the development of nanotechnology for drug delivery. Currently, more pharmaceutical organizations and companies as well as institutes invest in the biomimicking nanomedicine, which is supposed to be more effective with less side reactions as compared to traditional treatments.

Nanotechnology Drug Delivery Market Segment Analysis:

Nanotechnology Drug Delivery Market Segmented on the basis of Formulation and application.

By Formulation, Polymer-based nanomedicine segment is expected to dominate the market during the forecast period

• The polymer based nanomedicine segment is expected to have the largest market share in the anticipated Nanotechnology Drug Delivery Market over the specified period owing to its flexibility and deployability in various ends.. Nanopolymers involve biocompatible and biodegradable polymers including PLGA, PCL and peg, to formulate nanoparticles for drug delivery, which can release and deliver drugs in a controlled manner. These polymers increase drug shelf-life, shield the drug from degradation, and provide long-lasting release; thus best suited for ailments such as cancer, cardiovascular health and autoimmune illnesses. It further extends their applicability across multiple therapeutic sectors since both hydrophilic and hydrophobic drugs can be encapsulated. Further, the polymer-based systems allow for the conjugation of targeting moiety which in turn enhances the drug delivery at specific site, say, tumour cell. Such an improved efficacy coupled with reduced side effects and the rising trend towards targeted and individualized treatments, makes polymer based nanomedicines a very significant growth segment in the market over the following years.

By Application, Oncology and Hematology segment expected to held the largest share

• Out of all the segments, Oncology and Hematology is anticipated to lead the demand in the Nanotechnology Drug Delivery Market through the forecast period due to increased cancer and blood disorder incidences globally. Nanotechnology has especially informed cancer treatment through delivering drugs to the cancerous cells with higher precision leaving the healthy tissues thus resulting to minimal side effects as is the case with most chemotheraphy and radiation. Polymeric particles in nano-dimensions; liposomes, dendrites, polymeric particles; have been effective in improving bio availability of anti - cancer drugs, controlling drug release and improving therapeutic index.
• Also, nanomedicine has proved to be effective in combating multidrug resistance in cancer-a major impediment towards management of cancer. Due to continuous research towards the application of nanotechnology in targeted cancer therapies, immunotherapy as well as combination therapies, the Oncology and Hematology segment reach its position to continue to grow as is this segment in a position to respond to the need which is growing daily for new and efficient cancer therapies.

Nanotechnology Drug Delivery Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• North America dominates the Nanotechnology Drug Delivery Market holding the largest market share in 2023. This region dominates the market due to better healthcare framework, higher spending on R&D and key pharmaceutical and biotechnology businesses. After reviewing the existing literature, the following authors identified that the United States, in particular, has numerous key industries and institutes including companies and academic institutions actively engaging in the modern advanced research in nanotechnology based drug delivery.
• Further, the policy support and legal environments within the region support the development of nanomedicine as a kind of industry. Given these circumstances, it is believed that North America will continue to be a dominant player and will contribute about 40% to 45% of the global market share by 2023 , due to the growing application of nanotechnology in cancer therapy, neurology and cardiovascular diseases. The leadership in the field of personal medicine and new therapeutics also strengthens the leadership of the region in the studied market.

Active Key Players in the Nanotechnology Drug Delivery Market

• AbbVie Inc. (USA)
• Amgen Inc. (USA)
• AstraZeneca (UK)
• Bausch Health Companies Inc. (Canada)
• Bristol-Myers Squibb (USA)
• Celgene Corporation (USA)
• Gilead Sciences (USA)
• GlaxoSmithKline (UK)
• Johnson & Johnson (USA)
• Merck & Co., Inc. (USA)
• Novartis International AG (Switzerland)
• Pfizer Inc. (USA)
• Roche Holding AG (Switzerland)
• Sanofi (France)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Other key Players

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Nanotechnology Drug Delivery Market by Formulation
 4.1 Nanotechnology Drug Delivery Market Snapshot and Growth Engine
 4.2 Nanotechnology Drug Delivery Market Overview
 4.3 Lipid-based nanomedicine
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Lipid-based nanomedicine: Geographic Segmentation Analysis
 4.4 Polymer-based nanomedicine
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Polymer-based nanomedicine: Geographic Segmentation Analysis
 4.5 Nanocrystals
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Nanocrystals: Geographic Segmentation Analysis
 4.6 Others
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Others: Geographic Segmentation Analysis

Chapter 5: Nanotechnology Drug Delivery Market by Application
 5.1 Nanotechnology Drug Delivery Market Snapshot and Growth Engine
 5.2 Nanotechnology Drug Delivery Market Overview
 5.3 Oncology and Hematology
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Oncology and Hematology: Geographic Segmentation Analysis
 5.4 Infectious diseases
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Infectious diseases: Geographic Segmentation Analysis
 5.5 Orthopedics
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Orthopedics: Geographic Segmentation Analysis
 5.6 Neurology
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Neurology: Geographic Segmentation Analysis
 5.7 Urology
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Urology: Geographic Segmentation Analysis
 5.8 Immunology
  5.8.1 Introduction and Market Overview
  5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.8.3 Key Market Trends, Growth Factors and Opportunities
  5.8.4 Immunology: Geographic Segmentation Analysis
 5.9 Others
  5.9.1 Introduction and Market Overview
  5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.9.3 Key Market Trends, Growth Factors and Opportunities
  5.9.4 Others: Geographic Segmentation Analysis

Chapter 6: Company Profiles and Competitive Analysis
 6.1 Competitive Landscape
  6.1.1 Competitive Benchmarking
  6.1.2 Nanotechnology Drug Delivery Market Share by Manufacturer (2023)
  6.1.3 Industry BCG Matrix
  6.1.4 Heat Map Analysis
  6.1.5 Mergers and Acquisitions
  
 6.2 ABBVIE INC
  6.2.1 Company Overview
  6.2.2 Key Executives
  6.2.3 Company Snapshot
  6.2.4 Role of the Company in the Market
  6.2.5 Sustainability and Social Responsibility
  6.2.6 Operating Business Segments
  6.2.7 Product Portfolio
  6.2.8 Business Performance
  6.2.9 Key Strategic Moves and Recent Developments
  6.2.10 SWOT Analysis
 6.3 AMGEN INC
 6.4 ASTRAZENECA
 6.5 BAUSCH HEALTH COMPANIES INC
 6.6 BRISTOL-MYERS SQUIBB
 6.7 CELGENE CORPORATION
 6.8 GILEAD SCIENCES
 6.9 GLAXOSMITHKLINE
 6.10 JOHNSON & JOHNSON
 6.11 MERCK & CO.
 6.12 INC
 6.13 NOVARTIS INTERNATIONAL AG
 6.14 PFIZER INC
 6.15 ROCHE HOLDING AG
 6.16 SANOFI
 6.17 TEVA PHARMACEUTICAL INDUSTRIES LTD
 6.18 OTHER KEY PLAYERS

Chapter 7: Global Nanotechnology Drug Delivery Market By Region
 7.1 Overview
 7.2. North America Nanotechnology Drug Delivery Market
  7.2.1 Key Market Trends, Growth Factors and Opportunities
  7.2.2 Top Key Companies
  7.2.3 Historic and Forecasted Market Size by Segments
  7.2.4 Historic and Forecasted Market Size By Formulation
  7.2.4.1 Lipid-based nanomedicine
  7.2.4.2 Polymer-based nanomedicine
  7.2.4.3 Nanocrystals
  7.2.4.4 Others
  7.2.5 Historic and Forecasted Market Size By Application
  7.2.5.1 Oncology and Hematology
  7.2.5.2 Infectious diseases
  7.2.5.3 Orthopedics
  7.2.5.4 Neurology
  7.2.5.5 Urology
  7.2.5.6 Immunology
  7.2.5.7 Others
  7.2.6 Historic and Forecast Market Size by Country
  7.2.6.1 US
  7.2.6.2 Canada
  7.2.6.3 Mexico
 7.3. Eastern Europe Nanotechnology Drug Delivery Market
  7.3.1 Key Market Trends, Growth Factors and Opportunities
  7.3.2 Top Key Companies
  7.3.3 Historic and Forecasted Market Size by Segments
  7.3.4 Historic and Forecasted Market Size By Formulation
  7.3.4.1 Lipid-based nanomedicine
  7.3.4.2 Polymer-based nanomedicine
  7.3.4.3 Nanocrystals
  7.3.4.4 Others
  7.3.5 Historic and Forecasted Market Size By Application
  7.3.5.1 Oncology and Hematology
  7.3.5.2 Infectious diseases
  7.3.5.3 Orthopedics
  7.3.5.4 Neurology
  7.3.5.5 Urology
  7.3.5.6 Immunology
  7.3.5.7 Others
  7.3.6 Historic and Forecast Market Size by Country
  7.3.6.1 Bulgaria
  7.3.6.2 The Czech Republic
  7.3.6.3 Hungary
  7.3.6.4 Poland
  7.3.6.5 Romania
  7.3.6.6 Rest of Eastern Europe
 7.4. Western Europe Nanotechnology Drug Delivery Market
  7.4.1 Key Market Trends, Growth Factors and Opportunities
  7.4.2 Top Key Companies
  7.4.3 Historic and Forecasted Market Size by Segments
  7.4.4 Historic and Forecasted Market Size By Formulation
  7.4.4.1 Lipid-based nanomedicine
  7.4.4.2 Polymer-based nanomedicine
  7.4.4.3 Nanocrystals
  7.4.4.4 Others
  7.4.5 Historic and Forecasted Market Size By Application
  7.4.5.1 Oncology and Hematology
  7.4.5.2 Infectious diseases
  7.4.5.3 Orthopedics
  7.4.5.4 Neurology
  7.4.5.5 Urology
  7.4.5.6 Immunology
  7.4.5.7 Others
  7.4.6 Historic and Forecast Market Size by Country
  7.4.6.1 Germany
  7.4.6.2 UK
  7.4.6.3 France
  7.4.6.4 Netherlands
  7.4.6.5 Italy
  7.4.6.6 Russia
  7.4.6.7 Spain
  7.4.6.8 Rest of Western Europe
 7.5. Asia Pacific Nanotechnology Drug Delivery Market
  7.5.1 Key Market Trends, Growth Factors and Opportunities
  7.5.2 Top Key Companies
  7.5.3 Historic and Forecasted Market Size by Segments
  7.5.4 Historic and Forecasted Market Size By Formulation
  7.5.4.1 Lipid-based nanomedicine
  7.5.4.2 Polymer-based nanomedicine
  7.5.4.3 Nanocrystals
  7.5.4.4 Others
  7.5.5 Historic and Forecasted Market Size By Application
  7.5.5.1 Oncology and Hematology
  7.5.5.2 Infectious diseases
  7.5.5.3 Orthopedics
  7.5.5.4 Neurology
  7.5.5.5 Urology
  7.5.5.6 Immunology
  7.5.5.7 Others
  7.5.6 Historic and Forecast Market Size by Country
  7.5.6.1 China
  7.5.6.2 India
  7.5.6.3 Japan
  7.5.6.4 South Korea
  7.5.6.5 Malaysia
  7.5.6.6 Thailand
  7.5.6.7 Vietnam
  7.5.6.8 The Philippines
  7.5.6.9 Australia
  7.5.6.10 New Zealand
  7.5.6.11 Rest of APAC
 7.6. Middle East & Africa Nanotechnology Drug Delivery Market
  7.6.1 Key Market Trends, Growth Factors and Opportunities
  7.6.2 Top Key Companies
  7.6.3 Historic and Forecasted Market Size by Segments
  7.6.4 Historic and Forecasted Market Size By Formulation
  7.6.4.1 Lipid-based nanomedicine
  7.6.4.2 Polymer-based nanomedicine
  7.6.4.3 Nanocrystals
  7.6.4.4 Others
  7.6.5 Historic and Forecasted Market Size By Application
  7.6.5.1 Oncology and Hematology
  7.6.5.2 Infectious diseases
  7.6.5.3 Orthopedics
  7.6.5.4 Neurology
  7.6.5.5 Urology
  7.6.5.6 Immunology
  7.6.5.7 Others
  7.6.6 Historic and Forecast Market Size by Country
  7.6.6.1 Turkey
  7.6.6.2 Bahrain
  7.6.6.3 Kuwait
  7.6.6.4 Saudi Arabia
  7.6.6.5 Qatar
  7.6.6.6 UAE
  7.6.6.7 Israel
  7.6.6.8 South Africa
 7.7. South America Nanotechnology Drug Delivery Market
  7.7.1 Key Market Trends, Growth Factors and Opportunities
  7.7.2 Top Key Companies
  7.7.3 Historic and Forecasted Market Size by Segments
  7.7.4 Historic and Forecasted Market Size By Formulation
  7.7.4.1 Lipid-based nanomedicine
  7.7.4.2 Polymer-based nanomedicine
  7.7.4.3 Nanocrystals
  7.7.4.4 Others
  7.7.5 Historic and Forecasted Market Size By Application
  7.7.5.1 Oncology and Hematology
  7.7.5.2 Infectious diseases
  7.7.5.3 Orthopedics
  7.7.5.4 Neurology
  7.7.5.5 Urology
  7.7.5.6 Immunology
  7.7.5.7 Others
  7.7.6 Historic and Forecast Market Size by Country
  7.7.6.1 Brazil
  7.7.6.2 Argentina
  7.7.6.3 Rest of SA

Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies

Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research